Follow us on Twitter and Facebook for the latest Class Action Lawsuit Settlement News!

 

Bayer Men’s One-A-Day Class Action Notice Plan Approved

By Matt O’Donnell

 

Bayer Men's One-A-Day vitaminsA California federal judge has given the green light to distribute a Class notice to California consumers covered by a class action lawsuit alleging Bayer falsely advertised the prostate health benefits of Bayer’s Men’s One-A-Day Vitamins.

U.S. District Judge Anthony J. Battaglia granted a joint motion for approval of the Class notice plan, which will be published online in the next few weeks. The notice will be directed to the following Class Members:

  • all persons who purchased One-A-Day Men’s Health Formula from March 2002 to May 31, 2010; and
  • all persons who purchased One-A-Day Men’s 50+ Advantage from April 2007 to May, 31, 2010.


Plaintiffs in the One-A-Day vitamin class action lawsuit accuse Bayer of misleading consumers into believing the multivitamins – which contain selenium — support prostate health, despite scientific evidence to the contrary.

According to the class action lawsuit, Bayer did not have “credible and reliable scientific support for the promise” that selenium consumption can reduce the risk of prostate cancer. It further alleged that recent clinical studies have shown that for some men, increased selenium consumption may actually increase the risk of prostate cancer.

Top Class Actions will publish the Settlement Administrator website for the Bayer Men’s One-A-Day Vitamins Class Action Lawsuit once it goes live.

The case is Johns v. Bayer Corp., Case No. 9-cv-1935, U.S. District Court, Southern District of California.

 

Sign up for our free newsletter to get updates on new class action lawsuits and settlements.

 

Updated March 6th, 2013

 

All class action and lawsuit news updates are listed in the Lawsuit News section of Top Class Actions

LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2013 Top Class Actions® LLC
Various Trademarks held by their respective owners

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

View all: